ticker,published_utc,title,publisher,url
EXEL,2025-11-12T11:38:10+00:00,High Growth Tech Stocks To Watch In The US This November 2025,Yahoo,https://finnhub.io/api/news?id=dae39797394d1aae03acbd4782a89172e90b0a8492dce12e1ee5898b2d709270
EXEL,2025-11-10T13:41:36+00:00,"Exelixis, Inc. (EXEL) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript",SeekingAlpha,https://finnhub.io/api/news?id=87d26c2c992750428fc3771e37c2b4b4947bde95769ab1ebbbc02f3983fa9a1e
EXEL,2025-11-06T21:39:00+00:00,"Exelixis: The STELLAR Win Is A Mixed Bag, But Things Look Positive Still",SeekingAlpha,https://finnhub.io/api/news?id=99f74fdbc497dc25546b3f4bfb80723aa1625b96346748671c203dcbbfea2d2d
EXEL,2025-11-06T21:05:00+00:00,Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in November,Yahoo,https://finnhub.io/api/news?id=d8608cddedf7b19a0f15078d212c548da5e0f36f0a8d9b1472df61e50e625ef4
EXEL,2025-11-06T09:56:00+00:00,"Company News for Nov 6, 2025",Yahoo,https://finnhub.io/api/news?id=e02233604244dcbd708abfaebd28cd71c72e0f4d9158f999ae5d1178ec8eeab2
EXEL,2025-11-06T00:18:29+00:00,"Exelixis (EXEL) Profit Margins Jump to 27%, Reinforcing Bullish Outlook on Accelerating Earnings",Yahoo,https://finnhub.io/api/news?id=688fef8ac79170fa3a16d6a2fa5b349cb4847d3db4034892ae44694102ea4ebc
EXEL,2025-11-05T22:10:07+00:00,Is Exelixis a Bargain After Recent Partnership and 11.7% Share Price Jump in 2025?,Yahoo,https://finnhub.io/api/news?id=cc967f9e8e9ae2c31571dccf42d32c6a5792311a73b74a0f3ec86159398a7458
EXEL,2025-11-05T15:52:00+00:00,"EXEL Tops Q3 Earnings Estimates, Cabometyx Fuels Product Sales",Yahoo,https://finnhub.io/api/news?id=c76d398223e0826e4c763e853f971f2bfa0e7e04c67e0280b224296690a33519
EXEL,2025-11-05T10:25:44+00:00,"Exelixis, Inc. 2025 Q3 - Results - Earnings Call Presentation",SeekingAlpha,https://finnhub.io/api/news?id=f4c464d81d84fbc853bf0bc8ac65af0eeb6944735f576cce6f6d7864a4d0c5f5
EXEL,2025-11-05T05:08:37+00:00,Exelixis Inc (EXEL) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...,Yahoo,https://finnhub.io/api/news?id=3ef9f82ad41326df145d1709b0ab0dae13e400dd089781b540d4c4a8e3f15f39
EXEL,2025-11-04T23:30:03+00:00,Exelixis (EXEL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates,Yahoo,https://finnhub.io/api/news?id=7e79dea15cc6e05cbfc78402a4ae09d147db26126ea97b94fa4c34c2bc6e576d
EXEL,2025-11-04T22:55:02+00:00,Exelixis (EXEL) Beats Q3 Earnings and Revenue Estimates,Yahoo,https://finnhub.io/api/news?id=bed5a1afa6b724a3186e65535f00031b2a1894f443779c3207d3f173a0c6ea81
EXEL,2025-11-04T21:55:35+00:00,Exelixis: Q3 Earnings Snapshot,Yahoo,https://finnhub.io/api/news?id=f8fcda82f7186d2e6a891533afe3982e3c0c4bfae43c0a70bb8cfba916e77abb
EXEL,2025-11-04T21:06:23+00:00,"Exelixis, Inc. (EXEL) Q3 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=3d901d0e5bcf02ed2f691e2daba5e5509959a987209d75d767c627faf9751901
EXEL,2025-11-04T21:05:00+00:00,Exelixis Announces Third Quarter 2025 Financial Results and Provides Corporate Update,Yahoo,https://finnhub.io/api/news?id=8bdd4cb783d32e311f46cdb210e03f0ef21a12530f4db1b14af3bb0df975c46e
EXEL,2025-11-04T11:38:10+00:00,Exploring 3 High Growth Tech Stocks in the US Market,Yahoo,https://finnhub.io/api/news?id=f0995ef62bf7e25ef5a3bad7d20713bbb91a1620141d7cba51ee75f5419d7307
EXEL,2025-10-31T17:38:10+00:00,High Growth Tech Stocks In US With Promising Potential,Yahoo,https://finnhub.io/api/news?id=2c37c6a53b36dd0743f8021ccab5af86f4c3e61085aaef02e41ee3f7c597e351
EXEL,2025-10-29T14:00:06+00:00,Adaptive Biotechnologies (ADPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release,Yahoo,https://finnhub.io/api/news?id=478fc0fae4f6f7c340c71ad99755eb432127cd28c0201cf87bc513de901622ae
EXEL,2025-10-28T17:38:14+00:00,High Growth Tech Stocks In The US Market With Promising Potential,Yahoo,https://finnhub.io/api/news?id=29d646102e7648c7b6c826367462091163d706604b239e37a089411fb4df7a98
EXEL,2025-10-28T16:24:05+00:00,"Exelixis, Inc. (EXEL) Gets Upgraded to Outperform from Market Perform by Leerink Partners",Yahoo,https://finnhub.io/api/news?id=eb73c33c2b7db4d99a1f930b23a8da48db12888d4487cb157d7db3f83ad3a0b4
EXEL,2025-10-28T14:00:13+00:00,Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth,Yahoo,https://finnhub.io/api/news?id=dc18a3299ed2ccede4efb5ae9164262ad1297d9e453db5ce546e82eaa4586fea
EXEL,2025-10-28T12:01:00+00:00,Merck kidney cancer drug succeeds in two large trials,Yahoo,https://finnhub.io/api/news?id=d66a847c8a0ee35fa7036f6fc01cfb51a5594356a35c02233d48d18064e3e5fe
EXEL,2025-10-27T16:10:02+00:00,Why Exelixis (EXEL) is Poised to Beat Earnings Estimates Again,Yahoo,https://finnhub.io/api/news?id=5c078b040e879a4ac1163e68ba8771054b20f9ea4f940343bf3b6e845e59a066
EXEL,2025-10-27T13:40:03+00:00,Here's Why Exelixis (EXEL) is a Strong Value Stock,Yahoo,https://finnhub.io/api/news?id=aff2df8f4faad8d9516bbca2588b64785953a2fb002737cbe4f66106703923fd
EXEL,2025-10-24T11:38:20+00:00,Exploring 3 High Growth Tech Stocks in US Market,Yahoo,https://finnhub.io/api/news?id=77fd8c79f0126e86fa6731956d2615d4ad77bb6080ac8576496bd74df39529d8
EXEL,2025-10-23T11:38:15+00:00,High Growth Tech Stocks in the US to Watch for October 2025,Yahoo,https://finnhub.io/api/news?id=812e1e36b4d80df0436e98b5b882d38a69978bbb9b88ff105acbd5a3b6d0de53
EXEL,2025-10-23T02:05:25+00:00,Exelixis (EXEL): Assessing Valuation After STELLAR-303 Trial Results and Market Reaction,Yahoo,https://finnhub.io/api/news?id=4ced9055794439e9e3fae8e7adaf88bbb5fec2fab2de527180ccdf6c326f61ef
EXEL,2025-10-22T20:13:45+00:00,Assessing Exelixis After Recent 8.6% Drop and Ongoing Regulatory Developments,Yahoo,https://finnhub.io/api/news?id=4fdd52f2bce0226f363833cbc4ec72f18a54d33e1f2598690bac000b7d017cc8
EXEL,2025-10-21T20:05:00+00:00,"Exelixis to Release Third Quarter 2025 Financial Results on Tuesday, November 4, 2025",Yahoo,https://finnhub.io/api/news?id=2aac7a6e92ee0619e38fcfa9becabfd37714c0127c49267ffb457a22e9347963
EXEL,2025-10-21T16:54:31+00:00,Exelixis (EXEL) Loses 12% on Cancer Treatment Trial Results,Yahoo,https://finnhub.io/api/news?id=fa72fb1c8af727d42cd8cd388f8bc6343c23173a03c8596b7aa8d0d814d9b7fb
EXEL,2025-10-21T13:32:58+00:00,"Goldman downgraded, Coinbase initiated: Wall Street's top analyst calls",Yahoo,https://finnhub.io/api/news?id=75c1668e46d3601111440426ca57bf41b64627028382a17daa1cf55eb651f98b
EXEL,2025-10-21T12:38:07+00:00,Exelixis: Digesting The Big STELLAR-303 Update And The Road Ahead,SeekingAlpha,https://finnhub.io/api/news?id=c8aca42ea5b2b17a233699b28d55f4cfe72c4f550f1e386a1cee4bbc138c9376
EXEL,2025-10-21T11:00:00+00:00,SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress,Yahoo,https://finnhub.io/api/news?id=167d91f7ed0c64c0edd64b8b5be28c4f6b4630b298991023ed8fa59f82d4a836
EXEL,2025-10-20T20:29:22+00:00,"US Equity Markets Close Higher Amid Gains in Tech Stocks, Falling Government Bond Yields",Yahoo,https://finnhub.io/api/news?id=ab9cff138a8b55fafc9221829c7e964b64ed2572d2f62768b6c574fdf4ef3998
EXEL,2025-10-20T16:50:53+00:00,Update: Exelixis Shares Fall After Phase 3 Cancer Combo Trial Reports Mixed Results,Yahoo,https://finnhub.io/api/news?id=e5729b68a9b5f0a538a1df475708879961a9c27a745a3fd7a1ab7deef127f3cc
EXEL,2025-10-20T12:31:03+00:00,"Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Earnings Take Center Stage",Yahoo,https://finnhub.io/api/news?id=d90d42113c31c016c7d33745220ed08c63e426bbc3c4815c9cd56a823c978c11
EXEL,2025-10-20T11:38:07+00:00,Exploring High Growth Tech Stocks in the US This October 2025,Yahoo,https://finnhub.io/api/news?id=72c87f907699d9c61f08731374459edd380644c50c4dad2ef39d38c1cba87cef
EXEL,2025-10-20T09:01:12+00:00,Exelixis shares dip on colorectal cancer data,Yahoo,https://finnhub.io/api/news?id=4cf5d07cf8443c0a9ede499609305062ca0ff254794669a30edfac921c552285
EXEL,2025-10-20T06:30:00+00:00,Exelixis Announces Detailed Results from Phase 3 STELLAR-303 Pivotal Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Metastatic Colorectal Cancer Presented at ESMO 2025 and Published in The Lancet,Yahoo,https://finnhub.io/api/news?id=bd9edc0d8ed55fc49cf2d8f5fcd3efc51636d700ff6736026d42c787ecaf5043
EXEL,2025-10-18T07:00:00+00:00,Exelixis Announces Results from Subgroup Analysis of CABINET Phase 3 Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Advanced Lung and Thymic Neuroendocrine Tumors at ESMO 2025,Yahoo,https://finnhub.io/api/news?id=49514a3bd6375ddd02f5581e34192df45d7048c6375f6b549459ad61204b2e17
EXEL,2025-10-16T17:38:19+00:00,US High Growth Tech Stocks To Watch For Potential Expansion,Yahoo,https://finnhub.io/api/news?id=a249e3110eeb00f45439db75500feba477f7410d44888b8ec9f6d49447dfe152
EXEL,2025-10-14T11:30:00+00:00,The Ultimate Biotech Stock to Buy With $50 Right Now,Yahoo,https://finnhub.io/api/news?id=b472caa0ba0bb996fed276ea03b9f380a397f7ae80fe9f808a882d83dc637d6d
EXEL,2025-10-13T17:00:00+00:00,Pancreatic Endocrine Tumor Market Set to Witness Significant Growth During the Forecast Period (2025–2034) Owing to the Expected Launch of Therapies | DelveInsight,Yahoo,https://finnhub.io/api/news?id=e566bda1b0c8ccba9e4dfadb044fb3be36942d5d827dbfc711a81a3ad654d9c3
EXEL,2025-10-11T22:07:40+00:00,Is Upward Earnings Estimate Momentum Altering The Investment Case For Exelixis (EXEL)?,Yahoo,https://finnhub.io/api/news?id=e7ecb97acb296e72081dd914abebae0e0e7644a3ab85d3bd14c6cd12992988c2
EXEL,2025-10-09T13:40:03+00:00,Why Exelixis (EXEL) is a Top Value Stock for the Long-Term,Yahoo,https://finnhub.io/api/news?id=dfa4228dffea552beaeb5b0ec1fde603f15d44b4857a11260edbd1dfbb251bac
EXEL,2025-10-08T13:50:02+00:00,Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term,Yahoo,https://finnhub.io/api/news?id=1dceb8c14d64f027ae43750dd3e4d583415c138cdcc521f23694c80b9b269b55
EXEL,2025-09-30T08:10:00+00:00,Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years,Yahoo,https://finnhub.io/api/news?id=48e47391c2b7f641c814f009a24e51c5904aa0c355929c8a52883b2214bd2e65
EXEL,2025-09-27T04:59:18+00:00,Exelixis (EXEL) Rated Equalweight by Barclays Amid Cancer Drug Outlook,Yahoo,https://finnhub.io/api/news?id=e873caccc6508463b1bbe4f0bcba5a67bef6e5d513b3d5ed1dfb9f94abb2ce45
EXEL,2025-09-26T14:47:09+00:00,"Morgan Stanley Maintains Overweight Rating For Exelixis, Inc. (EXEL), Price Target Raised To $50",Yahoo,https://finnhub.io/api/news?id=ad70651df8e54e12c90c050146f6df4c8490e4553198569afa3a51c3ff357099
EXEL,2025-09-24T12:33:49+00:00,"Exelixis, Inc. (EXEL) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript",SeekingAlpha,https://finnhub.io/api/news?id=ef9d7e30e899e68767d803eaf612b40b9473477c367fe15cccae682a9fe1cc07
EXEL,2025-09-18T12:27:59+00:00,Could Access to SAFEbody Technology Shift Exelixis (EXEL) Pipeline Strategy in Oncology?,Yahoo,https://finnhub.io/api/news?id=82a74513b86cfe554218a942fa941e5cded1f0ecfccd6cac6cba974b3b93d9a1
EXEL,2025-09-17T14:33:19+00:00,"Netflix upgraded, Five Below initiated: Wall Street's top analyst calls",Yahoo,https://finnhub.io/api/news?id=6f04ba293e7bafcfb5742f154a80a10737b7e5f994c48bd5f4c727370ba6ed17
EXEL,2025-09-16T13:00:00+00:00,Adagene Expands SAFEbody® Collaboration and License Agreement with Exelixis to Develop Third Novel Masked Antibody-Drug Conjugate,Yahoo,https://finnhub.io/api/news?id=84269a927984d1686fe91d3d49e73cd6c621b92dfa9e7282f71721e4980c0844
EXEL,2025-09-10T10:20:36+00:00,"Exelixis, Inc. (EXEL) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript",SeekingAlpha,https://finnhub.io/api/news?id=ca3d1863b41ef4c4825e9bcb525e3654d317fd48fc34bc104fe503de5492ef74
EXEL,2025-09-09T13:06:05+00:00,"Exelixis, Inc. (EXEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript",SeekingAlpha,https://finnhub.io/api/news?id=244ada9468b310df36fc8a3b1de999d63a681daf23d9f4429050884293dfc7b3
EXEL,2025-09-08T21:00:21+00:00,Here's Why Exelixis (EXEL) is a Strong Momentum Stock,Yahoo,https://finnhub.io/api/news?id=5e27fe80d284c58e07302d1d0087f441f4eef2ef08c09da3f68fe6eb667bba62
EXEL,2025-09-06T06:13:07+00:00,Exelixis Appoints Longtime Veteran Dana T. Aftab as Head of R&D,Yahoo,https://finnhub.io/api/news?id=df29a9ddc3657593bba191661b478ed7640945706e6bc7767280e51bb9a9d91d
EXEL,2025-09-05T16:31:50+00:00,"Exelixis, Inc. (EXEL): A Bull Case Theory",Yahoo,https://finnhub.io/api/news?id=87ebc8fdfedd526f2a196d51b17bf530366999b6e7eaa978dcac10de11090115
EXEL,2025-09-03T19:43:19+00:00,"Exelixis, Inc. (EXEL) Presents At Citi's Biopharma Back To School Conference Transcript",SeekingAlpha,https://finnhub.io/api/news?id=76de395d7f5219ffe6a700be505a61ce33275f4e9153c78dcc9c8535c7a447df
EXEL,2025-09-03T15:43:17+00:00,"Exelixis, Inc. (EXEL) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)",SeekingAlpha,https://finnhub.io/api/news?id=6635d8c8420fe36aa5e3de4fa96a82ca8476566a59b7c2fa5c27e671bc3f6edd
EXEL,2025-09-02T09:57:13+00:00,Is Moderna Stock Underperforming the S&P 500?,Yahoo,https://finnhub.io/api/news?id=e6eec3e09cd26271831fd96cf69bd6177fe23518994d643046195320f5fe9345
EXEL,2025-08-29T21:47:00+00:00,"Exelixis Announces Appointment of Dana T. Aftab, Ph.D. as Executive Vice President, Research and Development",Yahoo,https://finnhub.io/api/news?id=9091c07571cfaa5dfadaa199a35739bb45529b1cf70d8f2594ce8dc866b6b6ee
EXEL,2025-08-29T17:42:00+00:00,Do Options Traders Know Something About Exelixis Stock We Don't?,Yahoo,https://finnhub.io/api/news?id=0880d4d8ea61fce94134711e803d29643b7606d8bc60ca5c713e9fe695946d9e
EXEL,2025-08-29T08:51:27+00:00,"Exelixis, Inc. (EXEL) Halts Phase 3 STELLAR-305 Trial",Yahoo,https://finnhub.io/api/news?id=1c461aa86e80d0eb47c1f647a9f3634ad9987fb76bbcab867de7fe50e635428c
EXEL,2025-08-28T15:30:03+00:00,Why Is Alkermes (ALKS) Up 4.7% Since Last Earnings Report?,Yahoo,https://finnhub.io/api/news?id=ba75f9ca9df52ffd05c0023bf2fc31ed25c7887f4b34495726bd1c91a815b0a7
EXEL,2025-08-27T20:05:00+00:00,Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September,Yahoo,https://finnhub.io/api/news?id=bb8eff162fe439ab211b8ac59c4a1fffd7b6c8e5de1a614bdcc8109f648e6e52
EXEL,2025-08-27T15:30:03+00:00,Why Is Exelixis (EXEL) Up 3.8% Since Last Earnings Report?,Yahoo,https://finnhub.io/api/news?id=a8d347ae13fa9ddb2597298ae3469b2c5c8d1febcd60042f46e439e501ad1f7f
EXEL,2025-08-26T13:31:00+00:00,Can Label Expansion of Cabometyx Fuel Further Growth for EXEL?,Yahoo,https://finnhub.io/api/news?id=ca775025c48a3c64449643ed1591e9f9bf64a3798b3493a0212fdb4ef90531a3
EXEL,2025-08-26T11:45:11+00:00,High Growth Tech Stocks in the US Market to Watch,Yahoo,https://finnhub.io/api/news?id=24e323f4e749dc8a3006f9e6c7294946afbc590723e72e5e023b48c701c711c8
EXEL,2025-08-25T12:45:00+00:00,Exelixis vs. Merck: Which Oncology Stock Is a Better Pick as of Now?,Yahoo,https://finnhub.io/api/news?id=e8ce0022f30d9ac7b595512ce752c1f427d1661cf8208bc5e9669d02ba1263b4
EXEL,2025-08-24T20:08:01+00:00,Tracking Renaissance Technologies (RenTec) 13F Portfolio - Q2 2025 Update,SeekingAlpha,https://finnhub.io/api/news?id=5af03a9d2830ba72b2e198c9657b545ae8d7d8941028d9d6e3cde20a2dffefca
EXEL,2025-08-22T10:16:16+00:00,Is Exelixis Still Attractive After Recent 13% Pullback and Strong Cash Flow Growth?,Yahoo,https://finnhub.io/api/news?id=7d979135604d0dc07785c36943a6c14e0c85cd85a74707e8b3c65d843bb50493
EXEL,2025-08-19T13:33:00+00:00,Will EXEL's Share Repurchase Program Boost Value for Investors?,Yahoo,https://finnhub.io/api/news?id=c521d3f3ba7196db25843dd815a47f9414b0acfbfd41009daa548780a1fc12ea
EXEL,2025-08-17T04:54:06+00:00,H.C. Wainwright Maintains Buy on Exelixis (EXEL) Despite STELLAR-305 Phase 3 Setback,Yahoo,https://finnhub.io/api/news?id=95a6e80870b242a332de1e4091643712cb8d17a10761f85c98596943a958885e
EXEL,2025-08-14T13:11:00+00:00,Exelixis Gains 15.6% YTD: How Should You Play the Stock?,Yahoo,https://finnhub.io/api/news?id=89ebbe80ffa4cba3825760fc1d1afccca49c9557883ae05049ae5714237a0246
EXEL,2025-08-13T12:52:00+00:00,Will Zanzalintinib Ease Out EXEL's Reliance on Cabometyx for Growth?,Yahoo,https://finnhub.io/api/news?id=39c0d26d75f4c4c0cfdc73fdb5edb4a2c3b5734d2b172198bc861833bff60f4f
EXEL,2025-08-05T13:10:00+00:00,Cabometyx Sales Miss Mark in Q2: What Does This Mean for EXEL Stock?,Yahoo,https://finnhub.io/api/news?id=74aadfdf38f85f372d0b0324082794bf0413beb87e972767faadab80e17d84a9
EXEL,2025-08-04T13:15:03+00:00,Don't Overlook Exelixis (EXEL) International Revenue Trends While Assessing the Stock,Yahoo,https://finnhub.io/api/news?id=934ec1a8d47ad64a57d5e7b17181013334a8dbcb7feb0f4e885c3cdc2f294266
EXEL,2025-07-31T21:35:00+00:00,Franklin Biotechnology Discovery Fund Q2 2025 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=d61632bb7ac932a66ab21f6c57260f4bb79e88518f44428ce4f279a1392e761e
EXEL,2025-07-31T12:27:25+00:00,"Exelixis: Zanzalintinib Sees Mixed Progress, Cabozantinib Grinds Upwards",SeekingAlpha,https://finnhub.io/api/news?id=8770a37d94aff407493258b0b7cb324d41cb551e04d4381c0a24ea94e579f768
EXEL,2025-07-30T16:45:02+00:00,"Is Exelixis (EXEL) a Solid Growth Stock? 3 Reasons to Think ""Yes""",Yahoo,https://finnhub.io/api/news?id=bc681dd15da6682389956a839e90268c968bca9d8a06e4efe0f4f13a59cafca5
EXEL,2025-07-30T12:05:05+00:00,Exelixis (EXEL) Tumbles 16.8% as Q2 Earnings Disappoint,Yahoo,https://finnhub.io/api/news?id=9baf3dd380bcc98694237bc28169ac38cfcc9a702a5f7a9d30cb61ec94355f6f
EXEL,2025-07-30T01:34:00+00:00,"2 Highly Ranked Stocks to Consider After Q2 Earnings: CLS, EXEL",Yahoo,https://finnhub.io/api/news?id=1446b0136a695c117e5e5ac4a20ce196d83be19abeb195b2b816ee033ad89d0a
EXEL,2025-07-29T16:00:03+00:00,All You Need to Know About Exelixis (EXEL) Rating Upgrade to Strong Buy,Yahoo,https://finnhub.io/api/news?id=8e80ed62076f0d4d7a1b2e8785f63ea423e0e1b40b06ad5ddbb8a296524827a7
EXEL,2025-07-29T13:38:00+00:00,"EXEL Q2 Earnings Top, Sales Miss on Lower Collaboration Revenues",Yahoo,https://finnhub.io/api/news?id=9d3c1ab032ee2d1506add51603611208e6ddcf09f3da5e7b5718f114301c4256
EXEL,2025-07-29T11:49:04+00:00,"Exelixis fall over 12% after revenue miss, halts zanzalintinib trial",Yahoo,https://finnhub.io/api/news?id=b1db6066b43ae665f72e7b10b28e2a2a538a848a8112c64574e1ff2a327ab4bb
EXEL,2025-07-29T07:05:54+00:00,Exelixis Inc (EXEL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Challenges,Yahoo,https://finnhub.io/api/news?id=dfc42d63c60ef7565f3e1e87bd7463750cd33b5e8e9ffb8af2b078228f36fbee
EXEL,2025-07-28T22:51:01+00:00,"Exelixis, Inc. (EXEL) Q2 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=a42e6d83631a8f7c67aa6046c810af5dfc3d24baeed721eb04865751561c956f
EXEL,2025-07-28T21:20:01+00:00,Exelixis (EXEL) Beats Q2 Earnings Estimates,Yahoo,https://finnhub.io/api/news?id=95a74ab8d152d2c3e589d9de9ebf0464912549d0cf89f1137f1e5bba772ef288
EXEL,2025-07-28T20:16:49+00:00,Exelixis: Q2 Earnings Snapshot,Yahoo,https://finnhub.io/api/news?id=de72a25904b63caa192ec46acb94ff7b3e00b5f27a1dc055f18e07db02bcbbee
EXEL,2025-07-28T20:05:00+00:00,Exelixis Announces Second Quarter 2025 Financial Results and Provides Corporate Update,Yahoo,https://finnhub.io/api/news?id=b3e382febdedcbcb62d861561eba5dfd52f27d78c59f25b85c8d504be96e5590
EXEL,2025-07-28T15:26:44+00:00,Morgan Stanley makes bold S&P 500 projection as U.S. dollar weakens,Yahoo,https://finnhub.io/api/news?id=23ef5ca2c852e7e582eb23bbb2e31ef2a6ebfd8e344183efc32e945b2e80fb44
EXEL,2025-07-28T11:38:05+00:00,High Growth Tech Stocks In The US To Watch This July 2025,Yahoo,https://finnhub.io/api/news?id=d2d9e8306b92f164a0ee961f57e42762e00a7eccb1105b9b1beae7876e4be339
EXEL,2025-07-28T06:07:44+00:00,Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT,Yahoo,https://finnhub.io/api/news?id=2a57b422ca5ad2c6a71437b1c8d9ba58f05023e8711b2b7c259d4e5b366404b4
EXEL,2025-07-24T21:04:00+00:00,Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors,Yahoo,https://finnhub.io/api/news?id=3b9de368b25eadbd223383fb0b81b1935c67f7fd5f78ff0f5a4a3ef5e1f56283
EXEL,2025-07-24T07:15:02+00:00,"XMHQ: The Recent Portfolio Rebalance Fuels Price Returns, But Still Appears Unattractive",SeekingAlpha,https://finnhub.io/api/news?id=9c8ce511d4d06e52e4ac13b2e0af4d6318b0b5d070af3e89e1950d615fa17109
EXEL,2025-07-23T15:00:10+00:00,Exelixis Gains Analyst Confidence as Cancer Studies Advances,Yahoo,https://finnhub.io/api/news?id=54271ad6e3987ea11ca2086b197b1bd47319ab1c4d041afdc31a8272fc5791e2
EXEL,2025-07-23T14:53:00+00:00,Exelixis' Q2 Earnings: Will Cabometyx Sales Drive Growth?,Yahoo,https://finnhub.io/api/news?id=b075ad33a2fae1ea109694c63355af51e54ee7cb3fe863247d3bc0027704fbbd
EXEL,2025-07-23T13:45:02+00:00,Here's Why Exelixis (EXEL) is a Strong Growth Stock,Yahoo,https://finnhub.io/api/news?id=6ac57f34592bf6bd62ae76f36764f3bbed28c2f79647b9e97310d567db252e88
EXEL,2025-07-23T13:15:02+00:00,What Analyst Projections for Key Metrics Reveal About Exelixis (EXEL) Q2 Earnings,Yahoo,https://finnhub.io/api/news?id=cc8c40439cd3b23f4803ae8beb8d7a6e6c96f61ee058d9bc49a9d88879898526
EXEL,2025-07-22T18:17:43+00:00,"Is Exelixis, Inc.'s (NASDAQ:EXEL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?",Yahoo,https://finnhub.io/api/news?id=1c1b23bedab8c2c0f760a3ae0b8d3d8bbd7a7e6e243a6f88b79b394f1e8f415d
EXEL,2025-07-22T14:00:10+00:00,Alkermes (ALKS) Expected to Beat Earnings Estimates: Should You Buy?,Yahoo,https://finnhub.io/api/news?id=f7ea6e5742cadf1657f458079a8c3a0c9c98c7b59194a666882691a4b358dd29
EXEL,2025-07-21T15:40:03+00:00,EXEL vs. ARGX: Which Stock Should Value Investors Buy Now?,Yahoo,https://finnhub.io/api/news?id=460666147cdda2c59aaca0dbb978a6c5054fa47e53ec57871e0122e144709c7e
EXEL,2025-07-21T14:00:04+00:00,Exelixis (EXEL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release,Yahoo,https://finnhub.io/api/news?id=487ce1c11e757c8066e4e43c09db6ec8bc4e70afbd468941d9fd4b830a085ecd
EXEL,2025-07-21T13:40:03+00:00,Why This 1 Value Stock Could Be a Great Addition to Your Portfolio,Yahoo,https://finnhub.io/api/news?id=c38c5a17770c43dabd38dd085fc152d4cb889465186ba2c0e206d045e5155872
EXEL,2025-07-20T10:30:00+00:00,Here's Why This $50 Healthcare Stock Could Be the Next $200 Winner,Yahoo,https://finnhub.io/api/news?id=b37ac9bc2ae913dbef91b952237e83e48e0ff0df6a106f567344be75d781332a
EXEL,2025-07-17T18:05:32+00:00,Ligand Pharmaceuticals Stock Earns 84 RS Rating,Yahoo,https://finnhub.io/api/news?id=2da30c73f69fd9d0930f3f8ec7c5f8df2b5ae494dd5f35a2206d54ecb01a85c0
EXEL,2025-07-15T17:08:04+00:00,Liquidia Stock Gets Relative Strength Rating Lift,Yahoo,https://finnhub.io/api/news?id=2406915fca685d999428419f114426e4c9aa59d899bece520247cbd37b830147
EXEL,2025-07-15T16:10:04+00:00,Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?,Yahoo,https://finnhub.io/api/news?id=e1f49bcefe8282c9928632b812ed51d11fcf5158600d488a13654d9b9cfc66e2
EXEL,2025-07-15T13:20:00+00:00,Tempus AI Raises 2025 Financial Outlook: What's Backing It?,Yahoo,https://finnhub.io/api/news?id=a90d6b2fc1b1082a1e2a3aa8b0df221b91a2eb681320414c44657fe7e3397f06
EXEL,2025-07-14T20:05:00+00:00,"Exelixis to Release Second Quarter 2025 Financial Results on Monday, July 28, 2025",Yahoo,https://finnhub.io/api/news?id=7e1da9f1a4236d73533455a3dd32b62409b1c136bbb9797f94f06b97131bbead
EXEL,2025-07-14T16:45:02+00:00,Exelixis (EXEL) is an Incredible Growth Stock: 3 Reasons Why,Yahoo,https://finnhub.io/api/news?id=496bcf61f08f412d11d4a664cc11e83f41a94579d5d5a395f77a715313e14a8c
EXEL,2025-07-10T18:24:49+00:00,Arcutis Biotherapeutics Stock Scores RS Rating Upgrade,Yahoo,https://finnhub.io/api/news?id=6b0736c071535438399a520676d90e61c98e89696c61c4afc37fb5825444c62b
EXEL,2025-07-08T01:37:21+00:00,Exelixis: I Was Wrong To Be Too Cautious (Rating Upgrade),SeekingAlpha,https://finnhub.io/api/news?id=d95a1e628d1df49c58e83ea7a113f2ac23b5fc23236cb3a9a7ec8dc3f1622c75
EXEL,2025-07-07T13:45:08+00:00,Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term,Yahoo,https://finnhub.io/api/news?id=fbbfbc41ac532085553cd7b0946b4f75e2d437dad60d286d9cbab09ce91036b8
EXEL,2025-07-07T13:22:00+00:00,Exelixis Surges 35.2% in Three Months: Buy or Sell the Stock?,Yahoo,https://finnhub.io/api/news?id=275a99752d246814df37eb1a656e0a8367f8a752db65e353e3db30575670f2b8
EXEL,2025-07-04T13:40:02+00:00,Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?,Yahoo,https://finnhub.io/api/news?id=7ba695524a75d63283373c1524ad9625a9ce2dddd5835a7e567ea72ae94b4fce
EXEL,2025-07-04T12:35:00+00:00,AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer,Yahoo,https://finnhub.io/api/news?id=e93788c50dab92c8acc4ebb4e22cc67819e04b09395e4d71d92ea48d7c8191e6
EXEL,2025-07-04T11:45:00+00:00,2 Stocks to Buy With Less Than $50,Yahoo,https://finnhub.io/api/news?id=e75db1c612e2941d81b7b484c215fb672885a190680e3f3463824e0d8d29adf6
EXEL,2025-07-03T15:40:02+00:00,EXEL or ARGX: Which Is the Better Value Stock Right Now?,Yahoo,https://finnhub.io/api/news?id=aa1025a60650df089e63826398d2d9858e369c26276f40497b0a64397d22a916
EXEL,2025-07-02T12:34:00+00:00,Vertex Gets EU Nod for New Cystic Fibrosis Drug Alyftrek,Yahoo,https://finnhub.io/api/news?id=5b36a74d200ab2b1a4a97f9bdf0c2793c7b78086429a77897cbf53cd56115c60
EXEL,2025-07-02T12:11:00+00:00,What's Fueling Tempus AI's Explosive Sales Growth?,Yahoo,https://finnhub.io/api/news?id=f736289550c7b98015a09c3ec85da18d8dd928b510d65da4e926d08811c71aaf
EXEL,2025-07-01T15:55:00+00:00,RCKT's IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance,Yahoo,https://finnhub.io/api/news?id=de81c82cec2d7537ba8639fb5ec62c6869c8bbeebbe58fafa376eb5aa50dc06a
EXEL,2025-06-30T14:40:00+00:00,Vor Bio Stock Skyrockets 250% in the Past Week: Here's Why,Yahoo,https://finnhub.io/api/news?id=6dd67a0be38864174d82a25976a53c602894388013514f82da7626a71c734340
EXEL,2025-06-30T14:32:00+00:00,"Zacks.com featured highlights include Exelixis, Lyft and Kinross Gold",Yahoo,https://finnhub.io/api/news?id=c8f15b26b27bd25acd767daf5e6cf7711aefefe3d837aa85f151a72e47cae12d
EXEL,2025-06-27T17:14:44+00:00,Incyte Stock Gets Relative Strength Rating Lift,Yahoo,https://finnhub.io/api/news?id=e36b2ac1199757d9d020d7c93d2b751739748368089b9eb8fa435b2a7d279a95
EXEL,2025-06-26T19:24:26+00:00,"Stephens Upgrades Exelixis (EXEL) Stock, Raises PT",Yahoo,https://finnhub.io/api/news?id=efb73cf2694bbb3b27f1455b24cb9922493edba7f0c2fa7ccc9b8a291d77e208
EXEL,2025-06-25T17:27:46+00:00,Exelixis (NasdaqGS:EXEL) Reports Positive Phase 3 Trial Results For Colorectal Cancer,Yahoo,https://finnhub.io/api/news?id=6cae69a78db164c3a0f2fdfcec5052a5d4c4dcb858305b3cb93a22f78ad93ed1
EXEL,2025-06-25T16:45:02+00:00,3 Reasons Growth Investors Will Love Exelixis (EXEL),Yahoo,https://finnhub.io/api/news?id=9e497fc84124c6b8387e76cb34b2ab5306695220b4aeb39f3c2d2b6bdd1465b4
EXEL,2025-06-25T13:40:02+00:00,Are You a Value Investor? This 1 Stock Could Be the Perfect Pick,Yahoo,https://finnhub.io/api/news?id=c4e919fea4d44c75fe7422d39a520a6ca38b57f739d78f43a65d397c56d6a31b
EXEL,2025-06-25T09:50:00+00:00,"The Zacks Analyst Blog Highlights Sprouts Farmers Market, Royal Gold, Thomson Reuters, Woodward and Exelixis",Yahoo,https://finnhub.io/api/news?id=a4ffc3622ae40ebbdd009ba289efc55149471d42e12a751ab8533e73fce07976
EXEL,2025-06-25T05:30:00+00:00,23 Stocks That Score High on What Counts in the 2025 Market,Yahoo,https://finnhub.io/api/news?id=be98845d169c5ef5e83b680669bae0769a05c580745dd304ecd4a0cbd19dff9b
EXEL,2025-06-25T04:01:44+00:00,Exelixis Q1 25 results boost stock and target price,Finnhub,https://finnhub.io/api/news?id=9c21c176eecbf8634335b6d18b56e63dfe0444a3b2a2b8e6cb9702ec54a3897f
EXEL,2025-06-25T04:01:44+00:00,Exelixis Q1 25 results boost stock and price target,Finnhub,https://finnhub.io/api/news?id=1389b5f218330aad9aa02540e17b17b1ef2ad41e19305a2587daf23f54ece865
EXEL,2025-06-24T14:42:00+00:00,Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains?,Yahoo,https://finnhub.io/api/news?id=38458f254339b4c3b62c8206ca07953ccea435abd06beb21858efb55c7869f9e
EXEL,2025-06-24T13:40:00+00:00,EXEL Stock Rises on Positive Data From Colorectal Cancer Study,Yahoo,https://finnhub.io/api/news?id=ec78ab15a54176d6f3131d16a7c6fd081afeece1ff982674fbe2a511f3eeb434
EXEL,2025-06-24T13:15:02+00:00,"Exelixis, Inc. (EXEL) Soars to 52-Week High, Time to Cash Out?",Yahoo,https://finnhub.io/api/news?id=28a95b909ffe586367f70fa69c3010dc413c0ccbda07105a1e1d6a5644589949
EXEL,2025-06-24T11:38:18+00:00,Exploring US High Growth Tech Stocks To Watch In June 2025,Yahoo,https://finnhub.io/api/news?id=f3f8a91b6382a3145a7b3b4fdf30be805830cd609fdbb37eb5ba4cfd10710d1d
EXEL,2025-06-24T11:29:00+00:00,Buy 5 High-Flying Non-Tech Nasdaq-Listed Stocks of H1 to Gain in H2,Yahoo,https://finnhub.io/api/news?id=2a38fff2cc52f9993362bfd4625c8a0f061fc8c2f1bcf952d1e33bfc0c88efbe
EXEL,2025-06-24T07:05:21+00:00,How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?,Yahoo,https://finnhub.io/api/news?id=cb700eced42942f32b89aa6b1db9b61e9aae83a1e55c221cf49ede3f215b25f1
EXEL,2025-06-23T18:17:41+00:00,Sector Update: Health Care Stocks Mixed in Afternoon Trading,Yahoo,https://finnhub.io/api/news?id=d20240f0ea6a2ce570aa76492e7bdfce60ea1c840a1211ef5e4fe93910c7fd8b
EXEL,2025-06-23T16:27:05+00:00,Exelixis Surges On Positive Results For Next-Gen Colon Cancer Drug,DowJones,https://finnhub.io/api/news?id=c07c5d0aa41bceea85be05564ef02550de76048c22287e0b829aca03067d6dd7
EXEL,2025-06-23T12:58:09+00:00,Exelixis: Zanzalintinib MOA Overcomes Competing CRC Regorafenib Treatment,SeekingAlpha,https://finnhub.io/api/news?id=be8be3559bf7e0f4eaf87b79a514cd65d1ba6ac4d6f6bab18978ffdc52aa7f3f
EXEL,2025-06-23T12:25:17+00:00,"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid Heightened Geopolitical Tensions",Yahoo,https://finnhub.io/api/news?id=f01de55717517142dfd325d50472714fcbd51269de3a08d102e0add630b7d2d8
EXEL,2025-06-23T09:30:00+00:00,Exelixis Shares Rise Following Positive Results from Cancer-Treatment Study,MarketWatch,https://finnhub.io/api/news?id=cd7707187562a0df53a1c23e8ef697ccaa87cffb7e7429b86f414aac4874bf55
EXEL,2025-06-23T09:18:03+00:00,"Genmab: This Is Anything But A Value Trap, Yet It Is Currently Priced As One",SeekingAlpha,https://finnhub.io/api/news?id=4e760033ba4821df79b081935dac0af426335dcaf89076ab9b635b322cd8a901
EXEL,2025-06-23T07:30:00+00:00,"S&P 500 Futures Drop in Premarket Trading; Exelixis, Circle Internet Group Lead",MarketWatch,https://finnhub.io/api/news?id=afb8a4067fab0e05e0c28658ac47f5b7043255f5bab26e0e4bb7a62adf15a543
EXEL,2025-06-23T05:04:24+00:00,"Premarket movers: Tesla, Northern Trust, Exelixis",MarketWatch,https://finnhub.io/api/news?id=a8c15e9b872a96c2e807c0bfaae684210fb687340a0ee34092b4d63bfe3b22be
EXEL,2025-06-22T21:00:00+00:00,Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer,Yahoo,https://finnhub.io/api/news?id=9d9a38f8b2be4a369c5f19ac00cafdcaa04bbcc7bc47467fdfd4d5d70670c51e
EXEL,2025-06-20T11:03:23+00:00,Exelixis' Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX(R) (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors,Finnhub,https://finnhub.io/api/news?id=ee1c0cb8fccdf3022b712d4386994e46b55a9fb6521a290f3bf552c23f06e2e6
EXEL,2025-06-20T10:54:00+00:00,Exelixis’ Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors,Yahoo,https://finnhub.io/api/news?id=c5e44ea1086b5c815e9b9a18c68f09490234e998ad0bd5985892794602f7fb3e
EXEL,2025-06-19T15:11:00+00:00,Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma,Yahoo,https://finnhub.io/api/news?id=cc59a33f76f48de1bdb6b1a5cd96bf79fbf3b5d0c628ff454b2a6225ddc69ef2
EXEL,2025-06-19T13:45:06+00:00,Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick,Yahoo,https://finnhub.io/api/news?id=82b02f8ffbc82ff35c62d95cb118e80ee34d49db061df97854394017adad0f45
EXEL,2025-06-19T11:20:27+00:00,Those who invested in Exelixis (NASDAQ:EXEL) three years ago are up 102%,Yahoo,https://finnhub.io/api/news?id=5ce14431e4e16d733065d9b9b55884198a46e788f7169206a1c2e9ff94f56657
EXEL,2025-06-13T08:51:00+00:00,"Zacks.com featured highlights include Flex, CVS Health, Urban Outfitters and Exelixis",Yahoo,https://finnhub.io/api/news?id=0dd7b432144949206a5bd3066543816c579167bdf460350d25feff3e898fd459
EXEL,2025-06-12T15:30:07+00:00,Why Is Exelixis (EXEL) Down 7.2% Since Last Earnings Report?,Yahoo,https://finnhub.io/api/news?id=c989d96e03d87a809d069218f384e7e16805b7d8ca840b17c8975edb41895b64
EXEL,2025-06-12T08:00:00+00:00,Can ‘reputational pull’ save biotech from pharma’s image problem?,Yahoo,https://finnhub.io/api/news?id=03d535ddeedc4c84e790f51e9d622a183eb803bce99fda663bbef783706eaae8
EXEL,2025-06-11T13:01:00+00:00,"3 Underfollowed Stocks on the Move Now (OLO, PLMR, EXEL)",Yahoo,https://finnhub.io/api/news?id=924409e4ad23a0f6836e1edc281c4d51cd47b25672a2983dbafbc232c6f0ff4c
EXEL,2025-06-11T01:11:23+00:00,Tracking RenTech's 13F Portfolio - Q1 2025 Update,SeekingAlpha,https://finnhub.io/api/news?id=052b117f799eed2c573d9cf928e9f7d274bca070d09deafdfe5c1b0b7e7e4a08
EXEL,2025-06-09T16:45:03+00:00,3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL),Yahoo,https://finnhub.io/api/news?id=c24169927f701798595b40624647d7cfa10b434abb997c8cc2d4ee148838a4f4
EXEL,2025-06-06T19:13:10+00:00,Kymera Therapeutics Stock Earns 92 RS Rating,Yahoo,https://finnhub.io/api/news?id=d260dbfd89138dcaee8d0e65d084ae61f37f0e6eb0605ee93a87314c256ec1c2
EXEL,2025-06-06T16:00:08+00:00,Are You Looking for a Top Momentum Pick? Why Exelixis (EXEL) is a Great Choice,Yahoo,https://finnhub.io/api/news?id=c615fbe9de6cec58fa3365faac74d90303cc353bb7ad60130afce4d9428a778e
EXEL,2025-06-06T01:37:47+00:00,"BofA Hikes Exelixis, Inc. (EXEL) Target Amid CRC Caution",Yahoo,https://finnhub.io/api/news?id=6a584033c081f2cbe27c954e98fd96b24e24f3492acb0fcd2399d2231e54ca16
EXEL,2025-06-05T12:00:55+00:00,This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues,Yahoo,https://finnhub.io/api/news?id=1b701cc09c139550793cbf1f1ccd0e82d38cbaa5636ad66c23b1ad59b48e44ae
EXEL,2025-06-04T14:18:00+00:00,Exelixis Stock Surges 28% YTD: Should You Buy Now or Sell?,Yahoo,https://finnhub.io/api/news?id=6ff8951fae135a20c061d354a9037297b2d9c371645bdc951fcd4177acdafe32
EXEL,2025-06-04T08:50:17+00:00,"Transcript : Exelixis, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 07",Finnhub,https://finnhub.io/api/news?id=d44748fb60fc3133d9aab29684b86f466457863c8e422c5d8623273fb2a1089c
EXEL,2025-06-03T12:20:16+00:00,"Transcript : Exelixis, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10",Finnhub,https://finnhub.io/api/news?id=945e5f35b58b8684bbc84fe61f27b3612aeaa9b992001fb1f1e32a5e4dc1eee6
EXEL,2025-05-30T13:35:00+00:00,Top 4 Value Stocks With Impressive PEG Ratios to Buy Now,Yahoo,https://finnhub.io/api/news?id=80277e67ba588f392219a103cf1ae88702ea2ce505a79e70e8eadc60f46642e1
EXEL,2025-05-30T12:00:00+00:00,2 Top Stocks to Buy With Less Than $100,Yahoo,https://finnhub.io/api/news?id=cf8f22e192f8ebda766218664b4b266848710de3b9ff7ec16e7fba8cb9b9f01d
EXEL,2025-05-27T17:05:25+00:00,"Transcript : Exelixis, Inc. Presents at TD Cowen's 6th Annual Oncology Innovation Summit, May-27-2025 02",Finnhub,https://finnhub.io/api/news?id=82901a7e1bc5c736cb6a9d1306f901ffd5fbb1458a5f0d8cd83a336dd7c132c9
EXEL,2025-05-23T16:20:02+00:00,Earnings Estimates Moving Higher for Exelixis (EXEL): Time to Buy?,Yahoo,https://finnhub.io/api/news?id=cb6bfe8a6544bf90905b81b64048d233f004b0fe17ed77e0783c23187a091e7a
EXEL,2025-05-23T16:00:08+00:00,Exelixis (EXEL) Upgraded to Buy: What Does It Mean for the Stock?,Yahoo,https://finnhub.io/api/news?id=bc558d18ab0eb691b54830d3141875cf2194d972951d795a7a422d13fca2d91b
EXEL,2025-05-23T15:40:07+00:00,EXEL vs. ARGX: Which Stock Is the Better Value Option?,Yahoo,https://finnhub.io/api/news?id=663a9a374036ca05a78916be060c5c3a4594f67f52715f4af8d54f6ddd40b610
EXEL,2025-05-23T13:57:00+00:00,EXEL Reports Superior Efficacy Data From Kidney Cancer Study Cohort,Yahoo,https://finnhub.io/api/news?id=b80fb798dae8544fb737701ecbac0f200d51112578b2775cd7f2b544a3fdf896
EXEL,2025-05-23T10:38:17+00:00,Solid Earnings Reflect Exelixis' (NASDAQ:EXEL) Strength As A Business,Yahoo,https://finnhub.io/api/news?id=b2ac6596be08ddcf1dca5eebd15bf8fae59bf006d8feb4bb377de2f48c376a31
EXEL,2025-05-23T10:25:35+00:00,"Product Performance, Big Money Lift Exelixis",Yahoo,https://finnhub.io/api/news?id=10983546697273d7272561ef7a483fe69954d9e0050e160694c71562fac11c96
EXEL,2025-05-22T21:17:00+00:00,Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025,Yahoo,https://finnhub.io/api/news?id=3238bb8f6ed6ccef4dfe17886dfe3a442fdf289d941ed2b146ac4e3e6cd07d64
EXEL,2025-05-22T20:05:00+00:00,Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May and June,Yahoo,https://finnhub.io/api/news?id=86175fbf77904a77727281b420769f36a3652de7c9284a06083ded482500babb
EXEL,2025-05-22T14:33:00+00:00,"Wall Street Lunch: Bitcoin Breaches $111,000 Mark On Historic Pizza Day",SeekingAlpha,https://finnhub.io/api/news?id=240f3b35fb67f1d0c45fa1e4870e5a80f20995282922345748bd150cd7fefe4e
EXEL,2025-05-21T17:24:04+00:00,Exelixis (NasdaqGS:EXEL) Reports Robust Q1 2025 Earnings and Revenue Growth,Yahoo,https://finnhub.io/api/news?id=42d8a8d42a4c74738d8810ff5fee1291970731b6134663c55a599f64bb9b9fd3
EXEL,2025-05-20T11:50:21+00:00,"Transcript : Exelixis, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 10",Finnhub,https://finnhub.io/api/news?id=24e17f6d7ea034edcbdec722baef1ecd06a7ca291ef08ee80e67ad9bfcc3e3ed
EXEL,2025-05-19T19:07:00+00:00,ACADIA Pharmaceuticals Stock Sees RS Rating Jump To 93,Yahoo,https://finnhub.io/api/news?id=a76bce1b09057f9f034c088c3f956eae5130b3c2b0c61edcd99fa218131804a3
EXEL,2025-05-19T16:00:09+00:00,Exelixis (EXEL) is a Great Momentum Stock: Should You Buy?,Yahoo,https://finnhub.io/api/news?id=ace721352546fab25013d01a174dcb276f75f06d0e907108d5bd57d07cc1d043
EXEL,2025-05-19T13:50:09+00:00,Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick,Yahoo,https://finnhub.io/api/news?id=060018611433725b964c1995335d412f239bf05dea67fefd96ee308b3f7131c0
EXEL,2025-05-19T13:15:06+00:00,"Unlocking Exelixis (EXEL) International Revenues: Trends, Surprises, and Prospects",Yahoo,https://finnhub.io/api/news?id=b02645fe52b484e927bb3326f2fd9896730378b9defd3db9c0d0c31cb1d8b0f4
EXEL,2025-05-16T17:45:25+00:00,Exploring High Growth Tech Stocks in the US Market,Yahoo,https://finnhub.io/api/news?id=783cdaa8073fd57dbfc6a8cd1abb4aa8b434d7de76bda1ad9c46d1fa27817117
EXEL,2025-05-15T13:42:00+00:00,"Company News for May 15, 2025",Yahoo,https://finnhub.io/api/news?id=35fa903a1d37f8ff7243f5a4ce2bada1ae74ffe68f5e02a48f0398dd15b5b33c
EXEL,2025-05-14T23:56:20+00:00,"Why Exelixis, Inc. (EXEL) Skyrocketed On Wednesday",Yahoo,https://finnhub.io/api/news?id=bfa38b16269453d87d86b2577c635770f905b6984c41c7a9a35a9a78f9cec722
EXEL,2025-05-14T20:42:00+00:00,"These Stocks Moved the Most Today: Nvidia, AMD, Super Micro, UnitedHealth, eToro, Oklo, Exelixis, and More",Yahoo,https://finnhub.io/api/news?id=3dca276282d2b0ace44871b1325c98d047e80ddec2dc7bbb8a72796e1fa1a487
EXEL,2025-05-14T18:22:49+00:00,"eToro's Nasdaq debut, Exelixis outlook, Septerna–Novo deal",Yahoo,https://finnhub.io/api/news?id=73993d750dca5b7e62e25572728c4faa242fb60a5ae06a0c7e17b6efe2b0cca1
EXEL,2025-05-14T17:36:00+00:00,Health Care Roundup: Market Talk,DowJones,https://finnhub.io/api/news?id=f6dd3ef56639b299e8fb12c035814b8d8414ac248e0daae08e242bd4c089eb3a
EXEL,2025-05-14T15:33:36+00:00,Why Exelixis Stock Is Skyrocketing Today,Yahoo,https://finnhub.io/api/news?id=30ce5273ecd2f09af62dbd01f62e9da045cae29f7acc5bb0ed4354df56675cc3
EXEL,2025-05-14T14:53:34+00:00,Exelixis: A Notable Quarter,SeekingAlpha,https://finnhub.io/api/news?id=48e27fdd0e0396402ad3dcb5a6d060e383ae5ef947114413be8fc5307738c247
EXEL,2025-05-14T13:00:00+00:00,"EXEL Q1 Earnings Beat, 2025 Sales View Up as Cabometyx Drives Top Line",Yahoo,https://finnhub.io/api/news?id=5fc8fb101d64014d3603f860fd3d56aabc6599464b8db34c47a8fab9078abce1
EXEL,2025-05-14T12:40:35+00:00,Q1 2025 Exelixis Inc Earnings Call,Yahoo,https://finnhub.io/api/news?id=da1dc7f5f298a8650a90d1a1e2a6d86c318c7a36c22f6cc97549a4fa876aff5f
EXEL,2025-05-14T11:23:00+00:00,"These Stocks Are Moving the Most Today: Nvidia, AMD, Super Micro, UnitedHealth, Oklo, Exelixis, Grail, and More",MarketWatch,https://finnhub.io/api/news?id=40a4b41e0dbf058ffaac776415d3c5e882fa8d0951bf0509682686874fdb0bdb
EXEL,2025-05-14T07:31:00+00:00,"S&P 500 Futures Up in Premarket Trading; Aurora Innovation, OneStream Lag",MarketWatch,https://finnhub.io/api/news?id=95483759cd8173b9b41dccf1286978526630b81fa93eee71a1c2379874e9d506
EXEL,2025-05-14T07:18:41+00:00,Exelixis Inc (EXEL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...,Yahoo,https://finnhub.io/api/news?id=0a5d5d4a4f44b50a0aeeb0da23d77e66d33c80464c775bee95ce38a3bda820c2
EXEL,2025-05-14T04:33:57+00:00,Exelixis [NasdaqGS:EXEL] Sees US$555 Million Revenue With Earnings Up Sharply,Yahoo,https://finnhub.io/api/news?id=5a00b92483aba4b2b96dd7fb54054440605b27510e4b2fe1f12a31c1a40eef5e
EXEL,2025-05-13T22:00:04+00:00,Exelixis (EXEL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates,Yahoo,https://finnhub.io/api/news?id=f4fea306b1ca339c153a9bcaacd276f44ca18956d31f3b873b9715389678d4e3
EXEL,2025-05-13T21:20:03+00:00,Exelixis (EXEL) Surpasses Q1 Earnings and Revenue Estimates,Yahoo,https://finnhub.io/api/news?id=b4a22c689d031793589dcdfef70ada4431e62727fe66f30b5ef827d2281c614a
EXEL,2025-05-13T20:31:51+00:00,"Exelixis, Inc. (EXEL) Q1 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=a9e04dfb28d664cd3a9d51339a6f90f1ce1880cca6747254602580a5a217c350
EXEL,2025-05-13T20:23:52+00:00,Exelixis: Q1 Earnings Snapshot,Yahoo,https://finnhub.io/api/news?id=c5821eda0822b290b0fef3c08b5fd921c7fb477a26cc9f1158f76954a05ef507
EXEL,2025-05-13T20:07:00+00:00,Exelixis Announces First Quarter 2025 Financial Results and Provides Corporate Update,Yahoo,https://finnhub.io/api/news?id=49919d94a7252b647e1c7bda67f5c842041a550a2c0497ebe26b4d7b36bc0dae
EXEL,2025-05-13T20:03:24+00:00,Exelixis Catapults To Record High After Obliterating First-Quarter Expectations,Yahoo,https://finnhub.io/api/news?id=b247159b21367ebb2330d4eda93d7fcb0db5cbb7d7913f87a5794e69a5edcad8
EXEL,2025-05-13T19:08:00+00:00,"Stocks to Watch: American Eagle Outfitters, Exelixis, Everus Construction, Grail",MarketWatch,https://finnhub.io/api/news?id=24e6e1e33d9a59e0d52bac0637c0be28d2f190a02621ef7c2fd1863cb47e81de
EXEL,2025-05-13T18:56:52+00:00,"Dow Jones Futures: S&P 500 Erases 2025 Loss On Nvidia-Saudi Deal; Palantir, Carvana Break Out",DowJones,https://finnhub.io/api/news?id=717ac46bcf190f0a1fa2e94c86bd4b6df8ba5120963a0331be9fd7ceaafc1dbf
EXEL,2025-05-13T18:14:40+00:00,"Exelixis, Inc. 2025 Q1 - Results - Earnings Call Presentation",SeekingAlpha,https://finnhub.io/api/news?id=25574529ac7b7e08afe08dd4dacbd23838e942b248144a35dfb9995abdd638b2
EXEL,2025-05-13T18:06:00+00:00,"Invenra Highlights Exelixis? Initiation of Phase 1 Clinical Study Evaluating XB628, a First-in-Class Bispecific Antibody in Participants with Recurrent Advanced or Metastatic Solid Tumors",Finnhub,https://finnhub.io/api/news?id=bb3d4d0b82ba6e88187aa9c0fe0c27ec5fab7ba86a68d6559931d58668aa5ec9
EXEL,2025-05-13T17:04:04+00:00,Exelixis : 250513 Exelixis Q1 2025 Earnings Presentation With Appendix,Finnhub,https://finnhub.io/api/news?id=a8d311dfa1d40663d06f26d412d3ef14ae82cb3a85a53c71676dc441e5be5af5
EXEL,2025-05-13T16:35:00+00:00,"Exelixis Boosts Outlook After 1Q Profit, Revenue Rise",MarketWatch,https://finnhub.io/api/news?id=540d05d9ced09d8410d5bc02c607a6b2fdc1c0bfa25123930f76cb2333c1baf9
EXEL,2025-05-13T16:19:24+00:00,Biotech Leader Exelixis Pops After Obliterating First-Quarter Profit Expectations,DowJones,https://finnhub.io/api/news?id=096b46a710ec943b1665b37d77593ffdb6cf3b0db834064b0275671f73a834f9
EXEL,2025-05-13T16:05:00+00:00,"Transcript : Exelixis, Inc., Q1 2025 Earnings Call, May 13, 2025",Finnhub,https://finnhub.io/api/news?id=12e44b0eee945a5bbf85b7434dbc77174a40034c5d1bb3e2a452b289bde133b4
EXEL,2025-05-13T04:33:46+00:00,Under Armour and On Holding earnings to give update  on the sports apparel sector,MarketWatch,https://finnhub.io/api/news?id=cb803df15c2e6621c6f5bdf241322f6ef3522c1567be378606dee56108529700
EXEL,2025-05-11T20:52:45+00:00,"Is Exelixis, Inc. (EXEL) One of the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies?",Yahoo,https://finnhub.io/api/news?id=32ae0b297525507b86f698e0eb7ba929275cfc1cf4529c8d7fca5eb3bd5b1f13
EXEL,2025-05-09T05:37:08+00:00,Biotech Outperformance - Can't Take What's Already Earned,SeekingAlpha,https://finnhub.io/api/news?id=0db5d09571377e29c30a565fed1683e9dd97f245a019bebd05760af70e7b638e
EXEL,2025-05-08T13:15:17+00:00,Ahead of Exelixis (EXEL) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics,Yahoo,https://finnhub.io/api/news?id=0c7e697be74827c0452dfaba32700eaa251fce1c92e4eaaf0aec455902972deb
EXEL,2025-05-07T20:05:00+00:00,Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May,Yahoo,https://finnhub.io/api/news?id=2695a008eb738d190f1f977ad0d1dd6289ee59b49846a511e618c7da2f31945d
EXEL,2025-05-07T16:05:00+00:00,"Transcript : Exelixis, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 10",Finnhub,https://finnhub.io/api/news?id=63aa54f3e23f8b05e4204f96aee36670498b6d6bda79d602a8ad24f75533b827
EXEL,2025-05-03T18:47:42+00:00,"Exelixis, Inc. (EXEL): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy",Yahoo,https://finnhub.io/api/news?id=08fccc9a7fdc9878315d8d8c018916843039376acf6abafbf329f80815b54b6f
EXEL,2025-04-29T20:05:00+00:00,"Exelixis to Release First Quarter 2025 Financial Results on Tuesday, May 13, 2025",Yahoo,https://finnhub.io/api/news?id=f78b45df2b7b052d4407d3a3d3d37eadc4eb5f7072b452919d292b48c8a81974
